(Q40657200)

English

Effect of different renal function on antibacterial effects of piperacillin against Pseudomonas aeruginosa evaluated via the hollow-fibre infection model and mechanism-based modelling.

scientific article published on 26 May 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27231278%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Effect of different renal function on antibacterial effects of piperacillin against Pseudomonas aeruginosa evaluated via the hollow-fibre infection model and mechanism-based modelling (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27231278%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Pseudomonas aeruginosa

1 reference

based on heuristic

inferred from title

Juergen Bulitta

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27231278%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Carl Kirkpatrick

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27231278%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

David L Paterson

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27231278%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27231278%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Jason A. Roberts

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27231278%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Cornelia Barbara Landersdorfer

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27231278%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Steven C Wallis

6

object named as

Steven C Wallis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27231278%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Phillip J Bergen

1

object named as

Phillip J Bergen

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27231278%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Megan J McGregor

5

object named as

Megan J McGregor

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27231278%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

author name string

Kate E Rogers

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27231278%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

language of work or name

0 references

publication date

26 May 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27231278%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

number of pages

12

1 reference

based on heuristic

inferred from page(s)

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27231278%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

71

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27231278%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27231278%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

2509-2520

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27231278%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Pseudomonas aeruginosa is not just in the intensive care unit any more: implications for empirical therapy

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Development of resistance during antibiotic therapy

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Antibiotic resistance--what's dosing got to do with it?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Impact of Bolus dosing versus continuous infusion of Piperacillin and Tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Two compartment kinetic model with multiple artificial capillary units

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

PK/PD models in antibacterial development.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

ARC--augmented renal clearance

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Implications of Augmented Renal Clearance on Drug Dosing in Critically Ill Patients: A Focus on Antibiotics

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Update in sepsis and acute kidney injury 2014.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Pharmacodynamics of β-lactamase inhibition by NXL104 in combination with ceftaroline: examining organisms with multiple types of β-lactamases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic models.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Development of a new pre- and post-processing tool (SADAPT-TRAN) for nonlinear mixed-effects modeling in S-ADAPT.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Quantifying subpopulation synergy for antibiotic combinations via mechanism-based modeling and a sequential dosing design

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Interaction of drug- and granulocyte-mediated killing of Pseudomonas aeruginosa in a murine pneumonia model

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Relationship between ceftolozane-tazobactam exposure and selection for Pseudomonas aeruginosa resistance in a hollow-fiber infection model

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Application of pharmacokinetic-pharmacodynamic modeling and the justification of a novel fusidic acid dosing regimen: raising Lazarus from the dead.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Combination treatment with meropenem plus levofloxacin is synergistic against Pseudomonas aeruginosa infection in a murine model of pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Resistance emergence mechanism and mechanism of resistance suppression by tobramycin for cefepime for Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Impact of different carbapenems and regimens of administration on resistance emergence for three isogenic Pseudomonas aeruginosa strains with differing mechanisms of resistance

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW153

21 January 2018

Identifiers

10.1093/JAC/DKW153

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27231278%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27231278%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40657200&oldid=1794675925"